TGF-β1 [52], TIMP-2 [53], and VEGFR-2 [54] have been recognized in a number of studies as the key regulators of fibrogenesis and angiogenesis, which determined the choice of these biomarkers for detecting the effects of breast cancer treatment. The gene discussed is KDR; the disease is breast cancer.